Fortrea Holdings (FTRE) Deferred Taxes (2022 - 2026)
Fortrea Holdings (FTRE) posted Deferred Taxes of -$4.0 million for Q1 2026, up 47.37% on a QoQ basis from -$7.6 million in Q4 2025, and up 39.39% year-over-year from -$2.9 million in Q1 2025.
Fortrea Holdings (FTRE) Deferred Taxes (2022 - 2026) Analysis & Trends
Fortrea Holdings' Deferred Taxes history runs 5 years deep, the most recent figure standing at -$4.0 million for Q1 2026.
- Quarterly Deferred Taxes rose 39.39% year-over-year to -$4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$29.4 million (up 16.95% YoY) and the FY2025 annual result came in at -$32.0 million, down 30.08% from the prior year.
- Deferred Taxes was -$4.0 million for Q1 2026 at Fortrea Holdings, up from -$7.6 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $4.2 million in Q1 2024 and bottomed at -$28.3 million in Q4 2023.
- A 5-year average of -$8.0 million and a median of -$7.6 million in 2025 frame the typical range for Deferred Taxes.
- Peak annual rise in Deferred Taxes reached 216.67% in 2024, while the deepest fall reached 1655.56% in 2024.
- Fortrea Holdings' Deferred Taxes stood at -$9.7 million in 2022, then slumped by 191.75% to -$28.3 million in 2023, then jumped by 95.05% to -$1.4 million in 2024, then plunged by 442.86% to -$7.6 million in 2025, then soared by 47.37% to -$4.0 million in 2026.
- Business Quant data shows FTRE's Deferred Taxes at -$4.0 million in Q1 2026, -$7.6 million in Q4 2025, and -$7.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | -4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.00 Mn |
| Dec 31, 2025 | -7.60 Mn |
| Sep 30, 2025 | -7.60 Mn |
| Jun 30, 2025 | -10.20 Mn |
| Mar 31, 2025 | -6.60 Mn |
| Dec 31, 2024 | -1.40 Mn |
| Sep 30, 2024 | -11.60 Mn |
| Jun 30, 2024 | -15.80 Mn |
| Mar 31, 2024 | 4.20 Mn |
| Dec 31, 2023 | -28.30 Mn |
| Sep 30, 2023 | -8.80 Mn |
| Jun 30, 2023 | -900,000.00 |
| Mar 31, 2023 | -3.60 Mn |
| Dec 31, 2022 | -9.70 Mn |